ArticleACS biomaterials science & engineering2025
Electrospun PCL Mats Modified with Magnetic Nanoparticles and Tannic Acid with Antibacterial and Possible Antiosteosarcoma Activity for Bone Tissue Engineering and Cancer Treatment.
Article in ACS biomaterials science & engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Modifying scaffolds with agents that at the same time positively influence osteogenic cells and have a negative impact on cancerous growth, is a promising solution for patients with bone tissue defects following tumor excision. Such materials may not only boost tissue regeneration but also limit the risk of cancer reoccurrence. In our study, we developed novel bifunctional scaffolds containing magnetic nanoparticles grafted with PCL (MNP@PCL) and tannic acid (TA), which may be directed to support normal bone cells and suppress osteosarcoma cells. First, MNPs were postsynthetically surface-modified, by grafting poly(ε-caprolactone) (PCL) from the surface via ring opening polymerization of ε-caprolactone, to provide their uniform distribution within the polymer matrix. Then, fiber mats containing a fixed amount of MNPs (2 wt %) and increasing content of TA (0, 1, 5, and 10 wt %) were prepared by electrospinning method. Both MNP@PCL and TA decreased polymer crystallinity. The interaction between the MNPs and TA significantly influenced the mat morphology, thermal properties, and initial hydrolytic performance. The most intensive TA release was observed mainly within first 6 h of incubation, and it was 3.5-fold higher (ca. 0.02 mg of TA/per mg of mat) for mfPCL@TA-10 compared to mfPCL@TA-5. Moreover, TA-containing magnetic mats suppressed the metabolic activity of osteosarcoma cells. They also demonstrated enhanced antimicrobial properties against the bacteria typically accompanying orthopedic complications, reducing the population of Gram-positive bacteria by more than 90% compared to the neat PCL mat. This proves the high potential of these materials for combining cancer treatment with bone tissue engineering.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.